Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase

LINDSTEDT, S · 1992 · The Lancet

Abstract

Liver transplantation is the only effective treatment for hereditary tyrosinaemia type I (McKusick 276700). We have treated one acute and four subacute-chronic cases with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), a potent inhibitor of 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27), to prevent the formation of maleylacetoacetate and fumarylacetoacetate and their saturated derivatives. The oral daily dose was 0.1-0.6 mg/kg. The excretion of succinylacetoacetate and succinylacetone decreased from 15-103 mmol/mol creatinine to the detection limit or slightly above (ie, to 20-150 mumol/mol creatinine). The concentration of succinylacetone in plasma decreased from 5.8-43 mumol/l to the detection limit (0.1 mumol/l) over 2-5 months of treatment. The almost complete inhibition of porphobilinogen synthase in erythrocytes was abolished and the excretion of 5-aminolevulinate decreased to within or slightly above the reference range. The concentration of alpha-fetoprotein decreased in four patients to 1.3-7.5% of initially high values over 6-8 months. Improved liver function was reflected by normal concentrations of prothrombin complex and in decreased activities of alkaline phosphatase and gamma-glutamyltransferase in serum. Computed tomography revealed regression of hepatic abnormalities in three patients. One patient developed rickets 6 months before treatment and had excreted high concentrations of markers of tubular dysfunction--after 3 weeks of treatmen…

Overview

Integrity signals

Registry

Crossref · 10.1016/0140-6736(92)92685-9

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Cited by

See all 636

Metadata

Authors
LINDSTEDT, S.
Affiliations
Sahlgrenska University Hospital (SE)
Corresponding author
LINDSTEDT, S
Venue
The Lancet
Publisher
Elsevier BV
Published
1992-10
Volume
340
Issue
8823
Pages
813-817
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2045299448
Cited by
631
References
19
Citations by year
2026: 5 · 2025: 19 · 2024: 12 · 2023: 15 · 2022: 21 · 2021: 20 · 2020: 24 · 2019: 28 · 2018: 19 · 2017: 40 · 2016: 19 · 2015: 24 · 2014: 21 · 2013: 20 · 2012: 17
FWCI
10.92
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
NTBC, succinylacetone, delta-aminolevulinic acid dehydratase, 5-aminolevulinic acid, alpha-fetoprotein, cirrhosis prevention, liver cancer risk, liver transplantation alternatives, rickets, tubular dysfunction
MeSH terms
Acetoacetates, alpha-Fetoproteins, Amino Acid Metabolism, Inborn Errors, Aminolevulinic Acid, Porphobilinogen Synthase, Child, Child, Preschool, Cyclohexanones, Erythrocytes, Heptanoates, Humans, Infant, Kidney Tubules, Liver, Nitrobenzoates, Phenylalanine, Phosphates, Proteinuria, Tyrosine, 4-Hydroxyphenylpyruvate Dioxygenase, Hydroxybenzoates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. https://app.cochat.ai/papers/10.1016/0140-6736(92)92685-9
The paper
LINDSTEDT, S. (1992). Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. The Lancet. https://doi.org/10.1016/0140-6736(92)92685-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.